Globe Newswire
ALLIANCE TRUST PLC At the close of business Friday 17 May 2024:
The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was
- excluding income, 1277.6p - including income, 1285.3p The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was
- excluding income, 1281.5p
- including... (continue reading...)
Berkeley, California, May 20, 2024 (GLOBE NEWSWIRE) -- In conjunction with May as Mental Health Awareness Month, preliminary results from a University of California, San Francisco (UCSF) clinical trial combining heat exposure with psychotherapy sessions showed reductions in depression. The study, led by Ashley E. Mason, PhD, a clinical psychologist at the UCSF Osher Center for Integrative Health and the UCSF Weill Institute for Neurosciences, tested an integrated... (continue reading...)
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:AXA Investment Managers S.A.(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the... (continue reading...)FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE / DEALING BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:AXA Investment Managers S.A.(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the... (continue reading...)LIVONIA, Mich., May 20, 2024 (GLOBE NEWSWIRE) -- Alta Equipment Group Inc. (NYSE: ALTG) (“Alta” or the “Company”), today announced that it intends to offer, subject to market and other conditions, $500 million in aggregate principal amount of its senior secured second lien notes due 2029 in a private offering (the “offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The notes... (continue reading...)
More Globe Newswire
View Older Stories-
Leading Proxy Advisory Firms Recommend Shareholders Vote “FOR” All of Crown Castle’s Director Nominees
-
Agrify Corporation Mutually Agrees to Terminate Plan to Merge with Nature’s Miracle
-
Nexxen Reports Results for the First Quarter Ended March 31, 2024
-
Reunion Neuroscience Announces Publication of Results from Early Preclinical Studies Demonstrating the Potential of RE104 for Development in Depressive Disorders
-
BrightSpring Health Services Announces Onco360® Was Selected as National Pharmacy Partner for OJEMDA™
-
SL Green Realty Corp. Announces Common Stock Dividend
-
Form 8.3 - Lok'n Store Group PLC
-
Form 8.3 - Equals Group PLC
-
Mesa Air Group Reports First Quarter Fiscal 2024 Results
-
Nicole Robinson Appointed President of DataPath Inc.
-
Wugen Announces RMAT and PRIME Designations for WU-CART-007 to Accelerate Regulatory Reviews and Plans to Present Positive Phase 2 Study Findings at European Hematology Association (EHA) 2024 in June
-
Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024
-
Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024
-
Aveanna to Participate at the UBS Healthcare Services Cape Cod Summit and Jefferies Global Healthcare Conference
-
Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024
-
TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing
-
Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale
-
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
-
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference
-
Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale
-
Sono-Tek Announces Year-End FY 2024 Earnings Conference Call
-
Highest Performances Holdings Inc. (NASDAQ: HPH) to Announce Unaudited Financial Results For The First Half of The Fiscal Year 2024 and Host Conference Call on May 30, 2024
-
Arqit Quantum Inc. Announces Financial and Operational Results for the First Half of Fiscal Year 2024
-
New Campaign from The Trial for #ClinicalEquality – “Worth Less” –Spotlights the Cost of Clinical Inequality
-
Global-e Reports First Quarter 2024 Results
-
Enlight Announces Participation at Upcoming JP Morgan and Roth MKM Investor Conferences
-
Children International Hosts Ecuadorian Students in Kansas City for Global Finals of ‘Destination Imagination’ Tournament
-
Vivid Seats to Participate in William Blair’s 2024 Growth Stock Conference
-
ECARX Announces First Quarter 2024 Unaudited Financial Results
-
Ageas and Taiping deepen cooperation in pension solutions
-
At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 Diabetes
-
MAOCAT Presale Is Off to a Successful Start, Raising $300K Already
-
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel
-
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
-
Bayport Management Ltd announces standstill agreement and is in constructive negotiations with creditors to address its capital structure, cash interest obligations and debt maturities
-
Public Entities of America, LLC joins Apex Insurance Agency, LLC, part of Bridge Specialty Group, LLC
-
Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting
-
Scorpio Tankers Inc. Announces Agreement for a $223.6 Million Prepayment under its 2023 $1.0 Billion Credit Facility
-
Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Mu
-
Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
-
Voyageur Mineral Explorers Corp. Options Alberts Lake Project
-
The Board of Directors of Eezy Plc has resolved to change the target levels of the performance criteria for the fourth performance period of the share-based incentive plan for the company's key employ
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
-
Brunswick Corporation releases 2023 Corporate Sustainability Report
-
Resolutions of the Annual General Meeting of Shareholders of Aktsiselts Infortar
-
Man Group PLC : Form 8.3 - Redrow plc
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TYMAN PLC - Ordinary Shares
-
Man Group PLC : Form 8.3 - Tyman plc
-
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024